Atlas Trials

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Clinical trial NCT00845884 · UNKNOWN

Trial details

NCT number
NCT00845884
Sponsor
Rabin Medical Center
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Gastric Cancer
Start date
2009-02-01
Primary completion
2012-12-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.